Determination of Diabetes and Dyslipidemia Goals in the Management of Diabetes | Chapter 6 | New Frontiers in Medicine and Medical Research Vol. 14
Diabetes Type I and Type II have an increased risk of early atherosclerotic CVD, such as CHD and PAD [1], and it is well known that glucose control improves TG levels and cholesterol-lowering has beneficial effects on CVD outcomes in T1DM and T2DM. Author (S) Details Rajesh Jain Diabetes Prevention Control Project, National Health Mission, India. Susanne Olejas World Diabetes Foundation, Denmark. Sanjeev Davey Muzaffarnagar Medical College, India. Rachna Jain Department of Obstetrics & Gynecology, Jain Hospital, India. Reza Shoghli Department of Cardiology, Azad University of Tehran, Iran. Mohammad Iqbal Consultant Diabetes in Dubai and UK. Seyed Hoseyn Ahmadi Tafti Tehran Heart Centre, Tehran, Iran. Siyamak Jalal hosseini Tehran Heart Centre, Tehran, Iran. View Book :- https://stm.bookpi.org/NFMMR-V14/article/view/3388